Drive&Stake, the industry-first marketplace that empowers all mobility ecosystem participants to benefit from vehicle-generated data, launches today
2.11.2021 12:35:00 EET | Business Wire | Press release
Drive&Stake, a decentralised, scalable end-to-end solution for the creation of automated mobility data marketplaces, promotes industry-wide data exchange and enables participants within the mobility ecosystem to obtain extensive insights through real-time data analytics.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211102005028/en/
Over the past decades, the traditional idea of everyone possessing their own car as the primary means of mobility has shifted towards more interconnected ride-sharing, car-sharing and autonomous (self-driving) vehicles. As a result, vehicles have become mobile hubs of data, generating and processing vast volumes of information. The generated data has the potential to become a key driver for the implementation of disruptive, data-driven business models and services.
However, the current infrastructure has limited communication with third-party frameworks, leaving data untapped and locked in centralised silos. As a consequence, original equipment manufacturers (OEMs) face a trade-off between opening up access to their data and retaining profits from exclusive control over it. Service providers, such as insurance or fleet management companies, are dependent on third-party analytics processes, while drivers have no control over produced data and its potential use.
Drive&Stake addresses these obstacles and empowers all participants in the mobility ecosystem to share, access and benefit from vehicle-generated data.
Service providers can reach a broader customer base, deliver enhanced customer experience, perform real-time settlement of liabilities and develop new products and features. OEMs can improve business processes and access consumer data in a transparent, auditable way, while drivers—in addition to more services at a lower cost—can enjoy a personalised customer experience and collect reward tokens for staking, consuming third-party services, swapping or exchanging for fiat currencies.
RIDDLE&CODE, the leading European blockchain interface company, is powering Drive&Stake with a flexible hardware stack and software-driven approach that unlocks data in a secure, confidential manner and tokenizes the produced data by pegging it to real-life objects. Ocean Protocol allows the exchange and monetisation of data and data-based services, overcoming the trade-off between the benefits of using private data and the risks of exposing it. Experts from EFS Consulting are transforming data into tangible use cases in close collaboration with vehicle manufacturers, mobility service providers, and insurance and energy corporations, while ELOOP has already deployed a successful use case, recording CO2 savings and mileage of electric vehicles.
“RIDDLE&CODE has built Confidential PID that enables the secure extraction of vehicle-generated data and controls how this data will be accessed and utilised,” said Thomas Fürstner, founder and CTO of RIDDLE&CODE. “This novel approach comes as a result of our extensive development efforts for other industries like fintech and energy, where RIDDLE&CODE successfully implements various encryption and trusted computing technologies,” he added.
“Curiosity for novel technologies is in the very DNA of EFS Consulting. We are delighted to channel this curiosity together with our partner RIDDLE&CODE,” said Christian Schaupp, Managing Director of EFS Consulting. “Drive&Stake is a project that reinvents the connected vehicle experience, and we are proud to be part of it. Together with RIDDLE&CODE and other industry-leading partners, we are creating new decentralised business models and services based on tokenized mobility data.”
“RIDDLE&CODE is a blockchain pioneer. They've been at the forefront of using trusted and verifiable IoT devices integrated with blockchains,” said Bruce Pon, CEO of Ocean Protocol. “Drive&Stake data will be a valuable addition to the Ocean Market and we’re very excited to create a new data economy together.”
“As a company committed to taking the sharing economy to the next level, ELOOP is delighted to be part of Drive&Stake. Today, we are deploying a first use case, recording CO2 savings and mileage of electric vehicles, and are keen to test and develop further use cases within the Drive&Stake ecosystem,” said Leroy Hofer, CEO at ELOOP.
Drive&Stake supports a variety of use cases, including pay-as-you-drive, networked parking for car-sharing, incentivised mobility patterns, sustainable EV battery and supply-chain traceability. Further use cases can be developed and implemented.
Businesses interested in exploring disrupting mobility solutions and gaining value from vehicle-generated data can contact RIDDLE&CODE for more information about joining Drive&Stake.
About RIDDLE&CODE
RIDDLE&CODE is Europe’s leading company for blockchain interface solutions. The company develops hardware and software stacks that combine the security of smart cards with blockchain and the Internet of Things (IoT). Together with its tier-one clients and partners, which include Daimler, BMW, Wien Energie and leading Dutch crypto exchange LiteBit, RIDDLE&CODE brings new business models to the fintech, energy, mobility and materials industries.
More information: www.riddleandcode.com
About EFS Consulting
EFS Consulting was established based on the idea of creating modular platform strategies within the automotive industry. Today, the consultancy company with offices in Vienna and Shanghai has expanded beyond the automotive sector with fields of competencies covering all aspects of a technological product life cycle. EFS is dedicated to empowering clients on a global scale to deliver better products, production and market solutions.
More information: www.efs.consulting
About ELOOP
ELOOP is a Vienna-based car-sharing startup with a focus on green mobility solutions and environmental protection. The company has the vision to change the way people get around in urban areas and take the sharing economy to the next level. With the power of blockchain, ELOOP has tokenized the revenue of its Tesla fleet and shares it with all ELOOP ONE token holders. The fleet of ELOOP consists purely of Tesla electric vehicles.
More information: eloop.at/en
About Ocean Protocol
Ocean Protocol is an on-ramp for data services into crypto ecosystems, using datatokens. Each datatoken is a fungible ERC20 token to access a given data service. Ocean smart contracts, Ocean libraries and Ocean-powered front ends make it easy to publish data services (deploy and mint datatokens) and consume data services (spend datatokens). Therefore, Ocean provides decentralised access control. The Ocean Protocol Foundation has allocated 20 million Ocean tokens for funding initiatives, including the Data Economy Challenge.
More information: oceanprotocol.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005028/en/
Contact information
Media contact:
Aysenur Yükselal Aji.
aysenur@riddleandcode.com
Contact: Sebastian Steinmayr
+43 162 2447167.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom